I recently reviewed the article by Zhou et al. [1] published in the January 2019 issue of the World Journal of Urology, entitled "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors". I assessed its methodological quality using 16-item AMSTAR2 [2] appraisal tool. According to AMSTAR2, the study scored 11 items out of 16 while lost points from items 2, 9, 12, 13 and 14 which were related to the issues of protocol registry, risk of bias (ROB) and heterogeneity, respectively. ROB was well assessed by appropriate tools but its result was not accounted into the analysis through meta-regression/subgroup analysis or sensitivity analysis which may due to the paucity of the included studies. No commentary on the likely impact of ROB in discussion as well. In addition, although no heterogeneity was observed, it was not mentioned in the discussion part.
Dear Editor,
I recently reviewed the article by Zhou et al. [1] published in the January 2019 issue of the World Journal of Urology, entitled "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors". I assessed its methodological quality using 16-item AMSTAR2 [2] appraisal tool. According to AMSTAR2, the study scored 11 items out of 16 while lost points from items 2, 9, 12, 13 and 14 which were related to the issues of protocol registry, risk of bias (ROB) and heterogeneity, respectively. ROB was well assessed by appropriate tools but its result was not accounted into the analysis through meta-regression/subgroup analysis or sensitivity analysis which may due to the paucity of the included studies. No commentary on the likely impact of ROB in discussion as well. In addition, although no heterogeneity was observed, it was not mentioned in the discussion part.
I suppose there was a typographical error to report "OR of − 1.01 and 95% CI of − 2.96 to 0.94 (p = 0.31)" for the median period to the first recurrence while it was mean difference not odds ratio.
Finally, to evaluate clinical significance, prediction interval (PI) was proposed in contrast to statistical significance presented by confidence interval (CI). I suggest that authors calculate prediction interval for evaluating clinical significances [3] for macrohematuria, frequency of urination and bladder irritation symptoms which were considered statistically significant.
As a conclusion, this was a well-written paper and most items were followed appropriately; non-critical weaknesses were observed there, so based on AMSTAR2, this study is classified as "Moderate" quality.
